CytoDyn Balance Sheet - Annual (OTCMKTS:CYDY)

Add to My Stocks
$0.6 $0.02 (3.23%) CYDY stock closing price Sep 20, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like CytoDyn, and helps in stock analysis. Financial strength can be guaged by performing CytoDyn stock analysis and by analyzing the balance sheet. Annual results are typically accompanied with the company releasing financial statements. CytoDyn had a long term debt of $- at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at CytoDyn operating cash flow and CytoDyn revenue also. CytoDyn debt to equity ratio is .

View latest 10 year balance sheet data to check CytoDyn financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jun - May201720162015201420132012201120102009
Cash1.77M9.64M1.05M4.88M--1.03M--
Marketable Securities---------
Receivables---------
Inventory---------
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets4.34M1.85M-------
Total Current Assets
6.12M11.49M2.03M5.44M-1.02M1.97M--
Property Plant & Equipment---------
Accumulated Depreciation---------
Net Property Plant & Equipment
---------
Investment & Advances---------
Other Non-Current Assets---------
Deferred Charges---------
Intangibles1.91M2.26M2.61M2.96M3.31M----
Deposits & Other Assets---------
Total Assets
8.05M13.78M4.67M8.42M4.15M1.07M1.99M--
Notes Payable1.05M-1.63M------
Accounts Payable4.28M2.46M5.01M1.28M1.11M----
Current Portion Long-Term Debt---------
Current Portion Capital Leases---------
Accrued Expenses-1.11M4.07M------
Income Taxes Payable---------
Other Current Liabilities-----3.78M5.91M--
Total Current Liabilities
6.14M3.58M10.72M2.16M3.22M5.03M6.99M--
Mortgages---------
Deferred Taxes/Income---------
Convertible Debt---2.33M1.15M----
Long-Term Debt--2.63M------
Non-Current Capital Leases---------
Other Long-Term Liabilities3.01M-2M------
Total Liabilities
9.15M3.58M15.37M4.5M4.38M5.04M7M-1M
Minority Interest---------
Preferred Stock------1.56M2M-
Common Stock Net--35.81M30.36M16.24M15.15M9.14M7.14M6.28M
Capital Surplus121.73M107.3M24.76M20.1M17.77M8.31M6.19M5.01M2.99M
Retained Earnings-122.98M-97.22M-71.52M-46.43M-34M-24.43M-16.96M-13.88M-10.14M
Treasury Stock---------
Other Liabilities----0.37M-0.41M-3.36M-4.85M-0.04M-
Shareholders Equity-1.1M10.2M-10.69M3.92M-0.22M-3.97M-5M--0.7M
Total Liabilities & Shareholders Equity8.05M13.78M4.67M8.42M4.15M1.07M1.99M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The latest CytoDyn stock price, and CytoDyn historical stock prices show the stock price movement over time, and the CytoDyn PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: Anything that the CytoDyn company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. CytoDyn had total assets of $8.05M.
  • Liabilities: The total liabilities of CytoDyn for the year 2017 total to $9.15M. Liabilities for a company like CytoDyn include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

CytoDyn Balance Sheet - Key Ratios